Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03371979
What this trial is testing

Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Aeglea Biotherapeutics 68
Testing effectiveness (Phase 2)UnknownNCT05228496
What this trial is testing

Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC

Who this might be right for
Lung Cancer, Small Cell
Zhejiang Cancer Hospital 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796089
What this trial is testing

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Trans Tasman Radiation Oncology Group 35
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06236997
What this trial is testing

Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06477523
What this trial is testing

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Sichuan University 57
Testing effectiveness (Phase 2)Study completedNCT02499770
What this trial is testing

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
G1 Therapeutics, Inc. 122
Testing effectiveness (Phase 2)UnknownNCT04698941
What this trial is testing

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Study completedNCT00004186
What this trial is testing

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 55
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06464068
What this trial is testing

AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY EXTENSIVE STAGE - EXTRAPULMONARY SMALL CELL CARCINOMA

Who this might be right for
Extrapulmonary Small Cell Carcinoma
Gruppo Oncologico Italiano di Ricerca Clinica 66
Testing effectiveness (Phase 2)Looking for participantsNCT06475209
What this trial is testing

Adebrelimab + Apatinib in SCLC Maintenance Therapy

Who this might be right for
SCLC
Tang-Du Hospital 60
Testing effectiveness (Phase 2)UnknownNCT04620837
What this trial is testing

Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy

Who this might be right for
Small Cell Lung Carcinoma
Chinese Academy of Medical Sciences 25
Testing effectiveness (Phase 2)Looking for participantsNCT06758700
What this trial is testing

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Thoracic NeoplasmsLung Neoplasms+1 more
Shanghai Pulmonary Hospital, Shanghai, China 15
Large-scale testing (Phase 3)UnknownNCT02772107
What this trial is testing

Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Chinese PLA General Hospital 132
Testing effectiveness (Phase 2)Looking for participantsNCT06437509
What this trial is testing

BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 66
Testing effectiveness (Phase 2)Ended earlyNCT00537511
What this trial is testing

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

Who this might be right for
Carcinoma, Small Cell
Celgene 22
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT01579929
What this trial is testing

Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT04562337
What this trial is testing

SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 67
Next Page